| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| POSEDEL RHEA J | Director | C/O AEHR TEST SYSTEMS, 400 KATO TERRACE, FREMONT | /s/Chris Siu, Attorney-in-Fact | 03 Jul 2025 | 0001055117 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AEHR | Common Stock | Award | $0 | +10.6K | +17.45% | $0.00 | 71.2K | 02 Jul 2025 | Direct | F1, F2 |
| holding | AEHR | Common Stock | 471K | 02 Jul 2025 | By Trust |
| Id | Content |
|---|---|
| F1 | One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. |
| F2 | The amount reported includes shares subject to unvested restricted stock units. Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2024 of 3,408 shares on 11/04/2024. The closing price was $11.23 per share. Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2025 of 1,409 shares on 4/2/2025. The closing price was $7.84 per share. Mr. Rhea Posedel received 18,115 shares due to the termination of the Company's ESOP plan on 04/25/2025. The closing price was $8.76 per share. |